death-1 (PD-1) and programmed death ligand-1 and 2 (PD-L1) such as Nivolumab,
Atezolimumab, and Pembrolizumab are being used for cell lung cancer. Monoclonal antibodies
have been further developed into conjugated monoclonal antibodies, which are combined with
other agents such as radiolabeled antibodies and chemo labeled antibodies. Cancer vaccines
have also been developed such as Sipuleucel-T, Gardasil, and Cervarix. These vaccines either
work as preventive vaccines or therapeutic vaccines. Adoptive cell transfer therapies is a new
therapy emerging in the immuno-oncology such as CAR-T Cell Therapy under, which Kymriah
and Yescarta are available.
The global immuno-oncology drugs market was valued at US$ 43,084.5 million in 2016 and is
expected to witness a robust CAGR of 14.9% over the forecast period (2017 – 2025).
Report includes chapters which deeply display the following deliverable about industry :
• Immuno-Oncology Drugs Market Research Objective and Assumption
• Immuno-Oncology Drugs Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Immuno-Oncology Drugs Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Immuno-Oncology Drugs Market, By Regions
• Immuno-Oncology Drugs Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Immuno-Oncology Drugs Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Immuno-Oncology Drugs Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Immuno-Oncology Drugs Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion